Literature DB >> 21289310

Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.

Adam R Hersperger1, Jeffrey N Martin, Lucy Y Shin, Prameet M Sheth, Colin M Kovacs, Gabriela L Cosma, George Makedonas, Florencia Pereyra, Bruce D Walker, Rupert Kaul, Steven G Deeks, Michael R Betts.   

Abstract

Recent data suggest that CD8+ T-cell effector activity is an important component in the control of HIV replication in elite controllers (ECs). One critical element of CD8+ T-cell effector function and differentiation is the T-box transcription factor T-bet. In the present study, we assessed T-bet expression, together with the effector proteins perforin, granzyme A (Grz A), granzyme B (Grz B), and granulysin, in HIV-specific CD8+ T cells from ECs (n = 20), chronically infected progressors (CPs; n = 18), and highly active antiretroviral therapy (HAART)-suppressed individuals (n = 19). Compared with the other cohort groups, HIV-specific CD8+ T cells among ECs demonstrated a superior ability to express perforin and Grz B, but with no detectable difference in the levels of Grz A or granulysin. We also observed higher levels of T-bet in HIV-specific CD8+ T cells from ECs, with an ensuing positive correlation between T-bet and levels of both perforin and Grz B. Moreover, HIV-specific CD8+ T cells in ECs up-regulated T-bet to a greater extent than CPs after in vitro expansion, with concomitant up-regulation of perforin and Grz B. These results suggest that T-bet may play an important role in driving effector function, and its modulation may lead to enhanced effector activity against HIV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289310      PMCID: PMC3083297          DOI: 10.1182/blood-2010-12-322727

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.

Authors:  J C Gea-Banacloche; S A Migueles; L Martino; W L Shupert; A C McNeil; M S Sabbaghian; L Ehler; C Prussin; R Stevens; L Lambert; J Altman; C W Hallahan; J C de Quiros; M Connors
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.

Authors:  Hiroshi Takata; Masafumi Takiguchi
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

4.  T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity.

Authors:  Viviany R Taqueti; Nir Grabie; Richard Colvin; Hong Pang; Petr Jarolim; Andrew D Luster; Laurie H Glimcher; Andrew H Lichtman
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

Review 5.  Apoptosis induced by the lymphocyte effector molecule perforin.

Authors:  Paul Bolitho; Ilia Voskoboinik; Joseph A Trapani; Mark J Smyth
Journal:  Curr Opin Immunol       Date:  2007-04-17       Impact factor: 7.486

6.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

7.  Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway.

Authors:  P Shankar; Z Xu; J Lieberman
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

8.  Cloning and characterization of a new member of the T-box gene family.

Authors:  W X Zhang; S Y Yang
Journal:  Genomics       Date:  2000-11-15       Impact factor: 5.736

9.  Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.

Authors:  Helen Horton; Ian Frank; Ruth Baydo; Emilie Jalbert; Justin Penn; Sean Wilson; John P McNevin; Matthew D McSweyn; Deborah Lee; Yunda Huang; Stephen C De Rosa; M Juliana McElrath
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

10.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.

Authors:  Asier Sáez-Cirión; Christine Lacabaratz; Olivier Lambotte; Pierre Versmisse; Alejandra Urrutia; Faroudy Boufassa; Françoise Barré-Sinoussi; Jean-François Delfraissy; Martine Sinet; Gianfranco Pancino; Alain Venet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

View more
  100 in total

1.  Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.

Authors:  Stephanie A Freel; Ralph A Picking; Guido Ferrari; Haitao Ding; Christina Ochsenbauer; John C Kappes; Jennifer L Kirchherr; Kelly A Soderberg; Kent J Weinhold; Coleen K Cunningham; Thomas N Denny; John A Crump; Myron S Cohen; Andrew J McMichael; Barton F Haynes; Georgia D Tomaras
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

Review 2.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

3.  Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy.

Authors:  Matthew P Morrow; Kimberly A Kraynyak; Cornelia L Trimble; Mark L Bagarazzi; Albert J Sylvester; Michael Dallas; Dawson Knoblock; Jean D Boyer; Jian Yan; Russell Vang; Amir S Khan; Laurent Humeau; Niranjan Y Sardesai; J Joseph Kim; Stanley Plotkin; David B Weiner
Journal:  Clin Cancer Res       Date:  2017-10-30       Impact factor: 12.531

4.  Early KLRG1+ but Not CD57+CD8+ T Cells in Primary Cytomegalovirus Infection Predict Effector Function and Viral Control.

Authors:  Aki Hoji; Iulia D Popescu; Matthew R Pipeling; Pali D Shah; Spencer A Winters; John F McDyer
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

5.  Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.

Authors:  Costin Tomescu; Fuh-Mei Duh; Rebecca Hoh; Anne Viviani; Kara Harvill; Maureen P Martin; Mary Carrington; Steven G Deeks; Luis J Montaner
Journal:  AIDS       Date:  2012-09-24       Impact factor: 4.177

6.  NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Authors:  Andrew Zloza; Frederick J Kohlhapp; Gretchen E Lyons; Jason M Schenkel; Tamson V Moore; Andrew T Lacek; Jeremy A O'Sullivan; Vineeth Varanasi; Jesse W Williams; Michael C Jagoda; Emily C Bellavance; Amanda L Marzo; Paul G Thomas; Biljana Zafirova; Bojan Polić; Lena Al-Harthi; Anne I Sperling; José A Guevara-Patiño
Journal:  Nat Med       Date:  2012-02-26       Impact factor: 53.440

7.  Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.

Authors:  Susan Johnson; Michael Eller; Jeffrey E Teigler; Sebastien M Maloveste; Bruce T Schultz; Damien Z Soghoian; Richard Lu; Alexander F Oster; Agnès-Laurence Chenine; Galit Alter; Ulf Dittmer; Mary Marovich; Merlin L Robb; Nelson L Michael; Diane Bolton; Hendrik Streeck
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

8.  High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control.

Authors:  Zaza M Ndhlovu; Lori B Chibnik; Jacqueline Proudfoot; Seanna Vine; Ashley McMullen; Kevin Cesa; Filippos Porichis; R Brad Jones; Donna Marie Alvino; Meghan G Hart; Eleni Stampouloglou; Alicja Piechocka-Trocha; Carl Kadie; Florencia Pereyra; David Heckerman; Philip L De Jager; Bruce D Walker; Daniel E Kaufmann
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

Review 9.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

10.  Metabolic pathway activation distinguishes transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.

Authors:  Fatema Z Chowdhury; Zhengyu Ouyang; Maria Buzon; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.